Stock·NYSE·Real Estate
Welltower Inc. (WELL)
- Market cap
- $169.23B
- P/E
- 104.28
- Dividend yield
- 1.31%
- Street target
- $262.50median of 22 analysts
- 52-week range
- $173.13 $255.20
The short version
Where WELL stands today, in four lines, and what CleaRank Financial AI makes of it.
WELL at a glance
Welltower Inc. (WELL): Buy, 69/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($233.43 and $216.09).
- Earnings WELL beat estimates in 6 of its last 8 quarters, yet fell the next day after 2 of those beats.
- Insiders Insiders bought $5.4M and made no open-market sales over the last 18 months.
- Valuation P/E of 104.3 against 44.7 for the Real Estate sector: a premium to peers (+133%).
Figures as of October 17, 2026.
CleaRank Financial AI
WELL, or Welltower Inc., receives a Buy rating from CleaRank with a model score of 69/100.
Trend adds the most to that score: the price is 8.70% above its 200-day average and 0.63% above its 50-day average, and the 50-day average is 8.03% above the 200-day. Valuation pulls the score down the most. The P/E of 104.28 is 133.3% above the sector median (a premium to peers), and the P/S of 13.25 is 27.4% above the sector median. Currently the 50-day average is $233.43 and the 200-day is $216.09. The price rose 36.51% across the past year.
Only on CleaRank
Figures we compute ourselves from WELL's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $234.90 is 0.6% above the 50-day simple moving average of $233.43.Price above its 200-day average ›
The price is 8.7% above the 200-day simple moving average of $216.09.50-day average above the 200-day ›
The 50-day average ($233.43) is 8.0% above the 200-day average ($216.09), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 75% of its 52-week range, between $173.13 and $255.20.
WELL share price
Pick a period: each tab shows how far WELL has moved over it, to the last close.
Today's trading
Where WELL sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 104.28 is 133.3% above the Real Estate median of 44.7.P/S below the sector median ›
The price-to-sales ratio of 13.25 is 27.4% above the sector median of 10.4.Profitable over the last 12 months ›
Net income over the last 12 months was $1.6B on revenue of $12.8B, a net margin of 12.1%.Beat estimates in most recent reports ›
WELL beat the EPS estimate in 6 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.31%, or $3.07 a share a year.
Key statistics
The headline figures for WELL.
As of October 17, 2026, WELL trades at $234.90, with a market value of $169.23B, a P/E ratio of 104.28 and a dividend yield of 1.31%.
What the numbers say
CleaRank Financial AI's reading of WELL's valuation, growth and risks.
WELL trades at a P/E of 104.28, compared with a Real Estate sector median of 44.7. That makes the P/E a premium to peers, sitting 133.3% above the sector median P/E. Its price-to-sales ratio of 13.25 is 27.4% above the sector median of 10.4. Market capitalisation stands at $169.2B, and trailing earnings are $2.25 a share.
Growth outpaces the sector: revenue grew 39.10% in the latest year, against a sector median of 11.0%. WELL keeps a net margin of 12.15% and an operating margin of 16.56%. Shareholders' capital earns 3.84%, below the sector median of 5.8%, measured as return on equity. Rounding out the fundamentals, WELL reports debt-to-equity of 0.41 and a trailing dividend yield of 1.31% ($3.07 a share a year).
In the most recent available report in our data, dated April 28, 2026, WELL beat the estimate by 10.00%. Reported EPS was $0.55 against the $0.5 analysts had expected. Even so, the share price fell 1.00% in the next session.
Over its last 8 reports, WELL topped the estimate 6 times, but beats have not guaranteed gains: the stock fell the next day after 2 of them. The largest of the earlier reactions came after the July 28, 2025 report, which beat the estimate by 2.27% while the stock rose 4.85%. The consensus EPS estimate stands at $2.88 for this fiscal year and $3.18 for next.
WELL's P/E of 104.28 is 133.3% above the sector median, which marks it as a premium to peers. That leaves less room for disappointing results, since they would be judged against a high bar. The average daily move is 1.05%.
WELL against the Real Estate sector
How WELL compares with the median Real Estate stock CleaRank tracks.
Price to earnings vs sector: WELL trades at a significant premium to sector peers (+133%), suggesting market expectations for superior growth or market position.
Return vs XLRE: Since May 6, 2025, WELL has gained 56.1% against a gain of 1.0% for XLRE.
Performance against XLRE
WELL and the Real Estate sector fund over the same days.
Revenue and earnings
How much WELL sells, and how much of it becomes profit.
Revenue growth: Revenue grew 35.8% in FY2025 to $10.7B, from $7.9B a year earlier.
Profit margin: The net margin was 9.0% in FY2025, down from 12.4% the year before.
Profitable: WELL earned $962M in FY2025.
Earnings reality check
Did WELL beat what analysts expected, and how did the stock react?
Earnings record: WELL beat the analyst estimate in 6 of the last 8 quarters.
Market reaction: The stock fell in the first session after 2 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Apr 28, 2026after close | $0.50 | $0.55 | +10.00% | -1.00% | +0.03% |
| Feb 10, 2026after close | $0.59 | $0.55 | -6.78% | +3.51% | +3.86% |
| Oct 27, 2025after close | $0.53 | $0.55 | +3.77% | -1.59% | -0.16% |
| Jul 28, 2025after close | $0.44 | $0.45 | +2.27% | +4.85% | +6.63% |
| Apr 28, 2025after close | $0.38 | $0.40 | +5.26% | +1.63% | +1.26% |
| Feb 11, 2025after close | $0.41 | $0.34 | -17.07% | +2.16% | +4.40% |
| Oct 28, 2024after close | $0.35 | $0.41 | +17.14% | +5.18% | +2.86% |
| Jul 29, 2024after close | $0.31 | $0.39 | +25.81% | +1.44% | +0.53% |
Reports after April 28, 2026 are not yet in our data.
As of October 17, 2026, WELL has beaten the analyst EPS estimate in 6 of its last 8 reported quarters and fell in the first trading session after 2 of those beats; its most recent report in our data, on April 28, 2026, came in 10.00% above the estimate and the stock moved -1.00% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 57.2, in neutral territory.RSI above 50 ›
An RSI of 57.2 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of WELL
The score, the reasoning behind it, and what could move the price next.
Welltower Inc. (WELL) is trending up. At $234.90 the stock sits 0.63% above its 50-day average of $233.43 and 8.70% above its 200-day average of $216.09. It is also near the top of its 52-week range: 7.95% below the high of $255.20 and 35.68% above the low of $173.13. The 50-day average is 8.03% above the 200-day, so the two averages point the same way as the trend.
Short-term and long-term price action disagree. Over the past month the price climbed 0.17%, but over the past three months it slipped 3.43%, while the past year brought a gain of 36.51%. On the last session, the price rose 0.12% even though volume came in 29.9% below its average. The 14-day RSI sits at 57.2, which is neutral territory, and the MACD line is negative.
Analyst upgrade ›
JP Morgan upgraded it to Overweight from Neutral on September 24, 2026.
Source: Analyst action, JP Morgan, September 24, 2026
Earnings beat ›
The April 28, 2026 report beat the EPS estimate by 10.00%, and the share price fell 1.00% in the first session after it.
Source: Earnings report, April 28, 2026
- The two nearest levels matter most: the 52-week high at $255.20 above the price, and the 50-day SMA at $233.43 below it.
- The 14-day RSI is 57.2, which is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- The share price fell 1.00% in the first session after the April 28, 2026 report. Over the last 8 reports, WELL beat estimates in 6 of them.
WELL's uptrend depends on the price holding above its 50-day average of $233.43 and its 200-day average of $216.09. A close below the 50-day would be the first sign of that trend weakening. If the shares pull back, the 50-day SMA at $233.43 is the first level they would reach.
The next level above the price is the 52-week high at $255.20.
Technical indicators
Momentum and trend for WELL, from its daily closes.
As of October 17, 2026, with WELL at $234.90, its 14-day RSI is 57.2 (neutral territory), its 50-day simple moving average is $233.43 and its 200-day is $216.09.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What WELL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, WELL's 1-year correlation of daily returns is +0.16 with S&P 500 (SPY), +0.05 with Nasdaq 100 (QQQ), -0.02 with Bitcoin (BTC) and +0.05 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
18 of 22 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $262.50 is 11.7% above the price.More buy ratings than three months ago ›
18 of 22 rate it a buy now, against 17 of 22 three months ago.
WELL Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 24, 2026 | JP Morgan | Upgrade | Overweight |
| Sep 21, 2026 | Evercore ISI Group | Maintains | Outperform |
| Sep 15, 2026 | Jefferies | Assumes | Buy |
| Sep 2, 2026 | Scotiabank | Maintains | Sector Outperform |
| Sep 1, 2026 | Morgan Stanley | Maintains | Overweight |
| Sep 1, 2026 | Wells Fargo | Maintains | Overweight |
As of October 17, 2026, 22 Wall Street analysts cover WELL: 18 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $219.00 to $292.00, with a median of $262.50, 11.7% above the price of $234.90.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
WELL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from WELL's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much WELL tends to move, against the market and on its own.
The long record
WELL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.05% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 56.8%, from October 2019 to April 2020, regained by July 2021.Most 1-year holds ended higher ›
69% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $48,183, against $42,058 in the S&P 500 (SPY).
WELL Drawdowns & Recovery
As of October 17, 2026, WELL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -56.8% (October 2019 to April 2020); it regained that peak by July 2021, 15 months after the low, and 69% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into WELL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: WELL beat the S&P 500 over this period: $48,183 against $42,058.
A $10,000 investment in WELL in October 2016 would be worth about $48,183 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to WELL, and which have not.
Strongest month, November: an average of +7.80%, up in 8 of 10 years.
Weakest month, March: an average of -3.86%, up in 3 of 10 years.
This month, October: has averaged -1.50%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, WELL's strongest calendar month has been November (average +7.80%, up in 8 of 10 years) and its weakest March (average -3.86%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in WELL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in WELL today could grow to about $23,020 by 2036 in the base case, with a 90th-percentile outcome near $84,282 and a 10th-percentile outcome around $6,287. The simulation models price only; at today's 1.31% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
WELL Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $328 for WELL by 2030 in the base case, from $235 today (1.4x over 4 years). The 10th-percentile path ends near $144. These are outcomes of a Monte Carlo simulation run on WELL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $169 | $255 | $385 | |
| 2028 | $155 | $278 | $496 | |
| 2029 | $148 | $302 | $614 | |
| 2030 | $144 | $328 | $745 | |
| 2031 | $142 | $356 | $892 |
Method: a lognormal simulation of WELL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
WELL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $5.4M on the open market.
As of October 17, 2026, WELL insiders reported no open-market sales and 2 open-market purchases worth $5.4M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Andrew Gundlach
Director
|
Buy | 10.0K | $2.4M |
| Aug 20, 2026 | Dennis G Lopez
Director
|
Grant | 73 | $17.3K |
| Jun 26, 2026 | Shankh Mitra
Chief Executive Officer
|
Grant | 3.9K | - |
| May 29, 2026 | Timothy Mchugh
President
|
Grant | 11 | $1.9K |
| May 29, 2026 | Shankh Mitra
Chief Executive Officer
|
Grant | 17 | $2.9K |
| May 27, 2026 | Shankh Mitra
Chief Executive Officer
|
Grant | 162 | - |
| May 21, 2026 | Dennis G Lopez
Director
|
Grant | 63 | $13.6K |
| May 1, 2026 | Kenneth J Bacon
Director
|
Grant | 2.6K | - |
| Feb 26, 2026 | Karen B Desalvo
Director
|
Grant | 1.1K | - |
| Feb 26, 2026 | Dennis G Lopez
Director
|
Grant | 1.8K | - |
| Feb 26, 2026 | Sergio David Rivera
Director
|
Grant | 1.1K | - |
| Feb 26, 2026 | Johnese M Spisso
Director
|
Grant | 1.1K | - |
| Feb 13, 2026 | Matthew Grant Mcqueen
Officer
|
Grant | 541 | - |
| Dec 31, 2025 | Dennis G Lopez
Director
|
Grant | 57 | - |
| Dec 16, 2025 | Timothy Mchugh
President
|
Grant | 500 | - |
| Nov 28, 2025 | John F Burkart
Chief Operating Officer
|
Grant | 39 | $8.1K |
| Nov 28, 2025 | Nikhil Chaudhri
President
|
Grant | 31 | $6.5K |
| Nov 28, 2025 | Joshua Fieweger
Officer
|
Grant | 177 | $30.2K |
| Nov 28, 2025 | Timothy Mchugh
President
|
Grant | 53 | $11.0K |
| Nov 28, 2025 | Matthew Grant Mcqueen
Officer
|
Grant | 71 | $14.8K |
| Nov 28, 2025 | Shankh Mitra
Chief Executive Officer
|
Grant | 64 | $13.3K |
| Nov 20, 2025 | Dennis G Lopez
Director
|
Grant | 62 | $12.3K |
| Aug 21, 2025 | Dennis G Lopez
Director
|
Grant | 73 | $12.2K |
| Jun 30, 2025 | Andrew Gundlach
Director
|
Buy | 20.0K | $3.0M |
| Jun 17, 2025 | Shankh Mitra
Chief Executive Officer
|
Grant | 495 | - |
| May 30, 2025 | John F Burkart
Chief Operating Officer
|
Grant | 141 | $21.8K |
| May 30, 2025 | Nikhil Chaudhri
President
|
Grant | 150 | $23.1K |
| May 30, 2025 | Timothy Mchugh
President
|
Grant | 61 | $9.4K |
| May 30, 2025 | Matthew Grant Mcqueen
Officer
|
Grant | 81 | $12.5K |
| May 30, 2025 | Shankh Mitra
Chief Executive Officer
|
Grant | 112 | $17.3K |
| May 22, 2025 | Dennis G Lopez
Director
|
Grant | 108 | $15.9K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.